Peroxisomes contain more than 50 proteins, and more than half of these participate in lipid metabolism. The objective of our studies is to characterize cellular, and molecular aspects of the phenomenon of peroxisome proliferation induced by structurally diverse compounds and delineate mechanisms of peroxisome proliferator- induced pleiotropic responses, including development of liver tumors. While the role of peroxisome proliferator-activated receptors (PPARs) in the transcriptional activation of responsive genes, and that sustained induction of massive peroxisome proliferation in hepatocytes is carcinogenic appear well established, there are critical gaps in our understanding of the: a) mechanisms by which PPARs participate in gene activation in a cell and species specific manner; and b) role of sustained transcriptional activation ofH2O2-generating peroxisomal fatty acid-oxidation, as well as the nature of downstream events that occur as a result of increased by generation of H2O2 by peroxisomal oxidases in the development of peroxisome proliferator-induced tumors. We now propose to focus on generating fundamental information, which can provide insights into the molecular complexity of unique pleiotropic responses induced by peroxisome proliferators.
Our specific aims are to: l) Analyze the differences in the expression, developmental regulation and transcriptional activation of peroxisomal beta-oxidation system, employing the peroxisomal fatty acyl-CoA oxidase gene (ACOX) promoter to direct E. coli beta-galactosidase, or urate oxidase in transgenic mice; 2) Explore the role of H202-generating peroxisomal oxidases in carcinogenesis using the in vitro/in vivo molecular approaches and delineate the mechanism by which H202 initiates the cascade of events leading to neoplastic transformation; 3) Investigate the natural course and full potential of mice with disrupted ACOX gene, and other gene(s) of the -oxidation system, and delineate the reasons for the susceptibility of ACOX-/- mice to liver tumor development; 4) Evaluate the functional role of rat deoxyuridine triphosphatase (dUTPase), which interacts with and inhibits PPARalpha:, and determine whether the extra 62 N- terminal amino acid PPARalpha-interacting portion present in rat dUTPase, but lacking in human dUTPase has any fictional significance; and 5) Identify and characterize proteins interacting with PPARs in order to understand the differential and cell specific control and activation of gene expression by structurally diverse peroxisome proliferators.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM023750-25
Application #
6180056
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1997-07-01
Project End
2001-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
25
Fiscal Year
2000
Total Cost
$401,811
Indirect Cost
Name
Northwestern University at Chicago
Department
Pathology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Huang, Jiansheng; Jia, Yuzhi; Fu, Tao et al. (2012) Sustained activation of PPAR? by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J 26:628-38
Vluggens, Aurore; Reddy, Janardan K (2012) Nuclear receptors and transcription factors in the development of fatty liver disease. Curr Drug Metab 13:1422-35
Bai, Liang; Jia, Yuzhi; Viswakarma, Navin et al. (2011) Transcription coactivator mediator subunit MED1 is required for the development of fatty liver in the mouse. Hepatology 53:1164-74
Huang, Jiansheng; Viswakarma, Navin; Yu, Songtao et al. (2011) Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice. Am J Pathol 179:703-13
Hall, Angela M; Brunt, Elizabeth M; Chen, Zhouji et al. (2010) Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice. J Lipid Res 51:554-63
Matsumoto, Kojiro; Huang, Jiansheng; Viswakarma, Navin et al. (2010) Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse. Carcinogenesis 31:318-25
Stumpf, Melanie; Yue, Xiaojing; Schmitz, Sandra et al. (2010) Specific erythroid-lineage defect in mice conditionally deficient for Mediator subunit Med1. Proc Natl Acad Sci U S A 107:21541-6
Vluggens, Aurore; Andreoletti, Pierre; Viswakarma, Navin et al. (2010) Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform [corrected]. Lab Invest 90:696-708
Jia, Yuzhi; Viswakarma, Navin; Fu, Tao et al. (2009) Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis. Gene Expr 14:291-306
Li, Hui; Gade, Padmaja; Nallar, Shreeram C et al. (2008) The Med1 subunit of transcriptional mediator plays a central role in regulating CCAAT/enhancer-binding protein-beta-driven transcription in response to interferon-gamma. J Biol Chem 283:13077-86

Showing the most recent 10 out of 104 publications